Wellington Management Group’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
Other funds holding COGT
JT
FFM
DM
TCM
Wellington Management Group's COGT Position: Q2 2026 in Review
Wellington Management Group increased its Cogent Biosciences (COGT) stake by 21% in Q2 2026, buying an estimated $26.8M and bringing the position to 4,343,977 shares worth $168M. The position accounts for 0.03% of the portfolio, ranked #423.
Wellington Management Group first reported a position in COGT in Q1 2018 and has held it in 18 quarters since. 324 funds tracked by Wall St. Rank hold COGT as of Q2 2026.
- Wellington Management Group held 4,343,977 shares of Cogent Biosciences worth $168M as of Q2 2026.
- Wellington Management Group bought 765,355 Cogent Biosciences shares in Q2 2026, an estimated $26.8M.
- Cogent Biosciences made up 0.03% of Wellington Management Group's portfolio in Q2 2026, its #423 holding.
- Wellington Management Group first reported a position in Cogent Biosciences in Q1 2018 and has held it in 18 quarters since.
- 324 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.
Based on Wellington Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.